Investment fund puts millions into Oncology Venture

Danish biotech company Oncology Venture has signed a deal with a European investment fund that has committed to buy new shares in the company for the sum of approximately SEK 300 million (USD 33.02 million).

Photo: /ritzau/Lars Krabbe

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles